NCT00925977View on ClinicalTrials.gov

Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents

NATerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Diabetes Type 1
Interventions
DRUG

insulin Glargine + Insulin Apidra

12 wees treatment with Insulin Glargine + Insulin Apidra

DRUG

Insulin NPH + Insulin Apidra: Active Comparator

Insulin NPH + Insulin Apidra: Active Comparator

Trial Locations (4)

Unknown

Soroka hospital, Bear Sheva

Rambam Hospital, Haifa

Health care unit- Jerusalem, Jerusalem

Schnider children medical center, Petah Tikva

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT00925977 - Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents | Biotech Hunter | Biotech Hunter